Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3093746
Reference Type
Journal Article
Title
Renal bone disease
Author(s)
Sprague, SM
Year
2010
Is Peer Reviewed?
Yes
Journal
Current Opinion in Endocrinology, Diabetes, and Obesity
ISSN:
1752-296X
EISSN:
1752-2978
Volume
17
Issue
6
Page Numbers
535-539
DOI
10.1097/MED.0b013e3283400945
Web of Science Id
WOS:000285066500007
Abstract
Purpose of review
Renal osteodystrophy is a complex disorder of bone associated with chronic kidney disease (CKD). Disturbances in mineral metabolism, which include, phosphate retention, hypocalcemia, vitamin D deficiency, and hyperparathyroidism develop early in the progression of CKD. The Kidney Disease: Improving Global Outcomes (KDIGO) has proposed a new classification system to understand the complex pathophysiology in mineral metabolism and bone disease. Understanding this pathophysiology has become especially important, as recent evidence has suggested that disordered mineral metabolism is associated with increased cardiovascular mortality and morbidity in patients with CKD.
Recent findings
This review discusses the effect of these disturbances on the skeleton and how they result in altered bone structure and turnover. The degree of hyperparathyroidism appears to affect bone turnover; however, bone biopsies appear to be the only definitive method to specifically diagnose the bone lesion.
Summary
This review will assist the clinician in the early identification of patients at risk of renal osteodystrophy. Therapeutic strategies could then be employed to prevent and correct these disturbances in mineral metabolism and, thus, avoid patient morbidity.
Keywords
adynamic bone disease; chronic kidney disease-mineral and bone disorder; hyperparathyroidism; osteitis fibrosa
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity